| Hans-Günter Meyer-Thompson | Fachveröffentlichungen
Dosing to Effect With Weekly and Monthly Subcutaneous and Daily Sublingual Buprenorphine: Post Hoc Analysis of a Phase 3 Clinical Trial.
Dosing to Effect With Weekly and Monthly Subcutaneous and Daily Sublingual Buprenorphine: Post Hoc Analysis of a Phase 3 Clinical Trial.
Lofwall MR, Nunes EV, Walsh SL, Bailey GL, Frost M, Budilovsky-Kelley NR, Banke Nordbeck E, Meyner S, Almgren P, Peterson S, Tiberg F.
J Addict Med. 2025 Apr 7. doi: 10.1097/ADM.0000000000001484. Epub ahead of print. PMID: 40193234.
https://journals.lww.com/journaladdictionmedicine/fulltext/9900/dosing_to_effect_with_weekly_and_monthly.484.aspx